These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2857752)

  • 1. Neutralizing antibodies to pertussis toxin in whooping cough.
    Granström M; Granström G; Gillenius P; Askelöf P
    J Infect Dis; 1985 Apr; 151(4):646-9. PubMed ID: 2857752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of pertussis toxin in causing symptoms of Bordetella parapertussis infection.
    Wirsing von König CH; Finger H
    Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):455-8. PubMed ID: 7957264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of erythromycin to prevent pertussis in newborns of mothers with pertussis.
    Granström G; Sterner G; Nord CE; Granström M
    J Infect Dis; 1987 Jun; 155(6):1210-4. PubMed ID: 2883239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxin-neutralizing antibodies in patients with pertussis, as determined by an assay using Chinese hamster ovary cells.
    Trollfors B; Krantz I; Sigurs N; Taranger J; Zackrisson G; Roberson R
    J Infect Dis; 1988 Nov; 158(5):991-5. PubMed ID: 3183431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitoxin in human pertussis immune globulins.
    Ferngren H; Granström M
    J Biol Stand; 1986 Oct; 14(4):297-303. PubMed ID: 2881931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathogenetic significance of Bordetella pertussis toxin].
    Finger H
    Immun Infekt; 1985 Apr; 13(2):47-9. PubMed ID: 2860059
    [No Abstract]   [Full Text] [Related]  

  • 7. Long term serologic follow-up after pertussis immunization.
    Blennow M; Granström M
    Pediatr Infect Dis J; 1990 Jan; 9(1):21-6. PubMed ID: 2300411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An enzyme-linked-immunosorbent assay method for detection of immunoglobulins to pertussis toxin.
    Zackrisson G; Lagergård T; Lönnroth I
    Acta Pathol Microbiol Immunol Scand C; 1986 Dec; 94(6):227-31. PubMed ID: 2437765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed outbreak of Bordetella pertussis and Bordetella parapertussis infection in Finland.
    Mertsola J
    Eur J Clin Microbiol; 1985 Apr; 4(2):123-8. PubMed ID: 2861090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.
    Watanabe M; Nagai M
    Infect Immun; 2001 Nov; 69(11):6981-6. PubMed ID: 11598073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis.
    Pittman M
    Rev Infect Dis; 1979; 1(3):401-12. PubMed ID: 233166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chick embryo, a model to study the lethal activity of pertussis toxin, infectivity of Bordetella pertussis, and their neutralization by immune sera.
    Calver GA; Burton WW; Gardell CY
    Can J Microbiol; 1993 Aug; 39(8):759-66. PubMed ID: 8106134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretory IgA against pertussis toxin and surface structures of Bordetella pertussis in saliva of children with culture proven pertussis.
    Frühwirth M; Wolf H; Heininger H; Guggenbichler JP; Stehr E
    Adv Exp Med Biol; 1995; 371B():777-83. PubMed ID: 7502896
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of neutralising human recombinant antibodies to pertussis toxin.
    Williamson P; Matthews R
    FEMS Immunol Med Microbiol; 1999 Apr; 23(4):313-9. PubMed ID: 10225291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the usefulness of Bordetella pertussis toxins for serodiagnosis of whooping cough].
    Chodorowska M; Kuklińska D
    Med Dosw Mikrobiol; 1998; 50(1-2):89-95. PubMed ID: 9857618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The concept of pertussis as a toxin-mediated disease.
    Pittman M
    Pediatr Infect Dis; 1984; 3(5):467-86. PubMed ID: 6093069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pertussis encephalopathy with a normal brain biopsy and elevated lymphocytosis-promoting factor antibodies.
    Davis LE; Burstyn DG; Manclark CR
    Pediatr Infect Dis; 1984; 3(5):448-51. PubMed ID: 6093068
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of Bordetella pertussis and Bordetella parapertussis infections in Tunisian hospitalized infants: results of a 4-year prospective study.
    Zouari A; Smaoui H; Brun D; Njamkepo E; Sghaier S; Zouari E; Félix R; Menif K; Ben Jaballah N; Guiso N; Kechrid A
    Diagn Microbiol Infect Dis; 2012 Apr; 72(4):303-17. PubMed ID: 22313629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological activities of pertussigen from Bordetella pertussis strains of various agglutinogen types.
    Watanabe M
    Microbiol Immunol; 1984; 28(5):509-15. PubMed ID: 6088952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pertussis (whooping cough) toxin and Bordetella pertussis whole-cell antibody levels in a healthy New Zealand population.
    Lau RC
    N Z Med J; 1989 Oct; 102(878):560-2. PubMed ID: 2554227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.